These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2119435)

  • 21. Structural characterization of the major adducts obtained after reaction of an ultimate carcinogen aflatoxin B1-dichloride with calf thymus DNA in vitro.
    Wood ML; Smith JR; Garner RC
    Cancer Res; 1988 Oct; 48(19):5391-6. PubMed ID: 3138022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of intermittent exposure to aflatoxin B1 on DNA and RNA adduct formation in rat liver: dose-response and temporal patterns.
    Sotomayor RE; Washington M; Nguyen L; Nyang'anyi R; Hinton DM; Chou M
    Toxicol Sci; 2003 Jun; 73(2):329-38. PubMed ID: 12700393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of various inducers on the activities of cytochrome P-450-mixed function oxidases and aflatoxin B1 activation in microsomes of hamster livers.
    Sunouchi M; Fukuhara M; Ohno Y; Takanaka A
    J Toxicol Sci; 1988 Nov; 13(4):193-204. PubMed ID: 3149679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative and qualitative characterization of aflatoxin B1 adducts formed in vivo within the ribosomal RNA genes of rat liver DNA.
    Irvin TR; Wogan GN
    Cancer Res; 1985 Aug; 45(8):3497-502. PubMed ID: 3926300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temporal patterns of DNA adduct formation and glutathione S-transferase activity in the testes of rats fed aflatoxin B1: a comparison with patterns in the liver.
    Sotomayor RE; Sahu S; Washington M; Hinton DM; Chou M
    Environ Mol Mutagen; 1999; 33(4):293-302. PubMed ID: 10398377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitation of aflatoxin B1-modified DNA using monoclonal antibodies.
    Groopman JD; Haugen A; Goodrich GR; Wogan GN; Harris CC
    Cancer Res; 1982 Aug; 42(8):3120-4. PubMed ID: 6807538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Excretion of an aflatoxin-guanine adduct in the urine of aflatoxin B1-treated rats.
    Bennett RA; Essigmann JM; Wogan GN
    Cancer Res; 1981 Feb; 41(2):650-4. PubMed ID: 6778611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of the isolated perfused rat liver to study carcinogen-DNA adduct formation from aflatoxin B1 and sterigmatocystin.
    Essigmann JM; Donahue PR; Story DL; Wogan GN; Brunengraber H
    Cancer Res; 1980 Nov; 40(11):4085-91. PubMed ID: 6781740
    [No Abstract]   [Full Text] [Related]  

  • 29. Aflatoxin B1-2,3-oxide as a probable intermediate in the covalent binding of aflatoxins B1 and B2 to rat liver DNA and ribosomal RNA in vivo.
    Swenson DH; Lin JK; Miller EC; Miller JA
    Cancer Res; 1977 Jan; 37(1):172-81. PubMed ID: 187331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA binding and adduct formation of aflatoxin B1 in cultured human and animal tracheobronchial and bladder tissues.
    Stoner GD; Daniel FB; Schenck KM; Schut HA; Sandwisch DW; Gohara AF
    Carcinogenesis; 1982; 3(11):1345-8. PubMed ID: 6817939
    [No Abstract]   [Full Text] [Related]  

  • 31. Quantitation of aflatoxin B1-DNA adducts in woodchuck hepatocytes and rat liver tissue by indirect immunofluorescence analysis.
    Zhang YJ; Chen CJ; Haghighi B; Yang GY; Hsieh LL; Wang LW; Santella RM
    Cancer Res; 1991 Mar; 51(6):1720-5. PubMed ID: 1900216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro.
    Essigmann JM; Croy RG; Nadzan AM; Busby WF; Reinhold VN; Büchi G; Wogan GN
    Proc Natl Acad Sci U S A; 1977 May; 74(5):1870-4. PubMed ID: 266709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of sex difference and dietary protein level on the binding of aflatoxin B1 to rat liver chromatin proteins in vivo.
    Prince LO; Campbell TC
    Cancer Res; 1982 Dec; 42(12):5053-9. PubMed ID: 6814751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alteration of aflatoxin B1 metabolic profiles and reduction of aflatoxin B1 mutagenicity by hepatic microsomes of rats fed butylated hydroxyanisole.
    Choi CY; Park SH; Park EH; Cha YN
    J Toxicol Sci; 1991 Feb; 16 Suppl 1():119-32. PubMed ID: 1920539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA binding, adduct characterisation and metabolic activation of aflatoxin B1 catalysed by isolated rat liver parenchymal, Kupffer and endothelial cells.
    Schlemper B; Harrison J; Garner RC; Oesch F; Steinberg P
    Arch Toxicol; 1991; 65(8):633-9. PubMed ID: 1747061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temporal patterns of covalent DNA adducts in rat liver after single and multiple doses of aflatoxin B1.
    Croy RG; Wogan GN
    Cancer Res; 1981 Jan; 41(1):197-203. PubMed ID: 7448760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracellular aflatoxin B1-binding proteins in rat liver.
    Dirr HW; Schabort JC
    Biochem Int; 1987 Feb; 14(2):297-302. PubMed ID: 3107567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aflatoxin metabolism in humans: detection of metabolites and nucleic acid adducts in urine by affinity chromatography.
    Groopman JD; Donahue PR; Zhu JQ; Chen JS; Wogan GN
    Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6492-6. PubMed ID: 3931076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissimilarity in aflatoxin dose-response relationships between DNA adduct formation and development of preneoplastic foci in rat liver.
    Root M; Lange T; Campbell TC
    Chem Biol Interact; 1997 Oct; 106(3):213-27. PubMed ID: 9413548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism of aflatoxin B1 and identification of the major aflatoxin B1-DNA adducts formed in cultured human bronchus and colon.
    Autrup H; Essigmann JM; Croy RG; Trump BF; Wogan GN; Harris CC
    Cancer Res; 1979 Mar; 39(3):694-8. PubMed ID: 427755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.